First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC ‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug-Reference-Cited by-同舟云学术

First‐in‐Human, Healthy Volunteers Integrated Protocol of ETC ‐206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug

Published:2019-09-09 Issue:1 Volume:13 Page:57-66
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clin Transl Sci

Author:

Teneggi Vincenzo¹,Novotny‐Diermayr Veronica¹,Lee Lay Hoon¹,Yasin Maryam¹,Yeo Pauline¹,Ethirajulu Kantharaj¹,Gan Sylvia Bong Hwa¹,Blanchard Stephanie E.¹,Nellore Ranjani¹,Umrani Dhananjay N.¹,Gomeni Roberto²,Teck Darren Lim Wan³,Li Greg³,Lu Qing Shu⁴,Cao Yang⁴,Matter Alex¹⁵

Affiliation:

1. D3 (Drug Discovery and Development) A*STAR Singapore Singapore

2. Pharmacometrica La Fouillade France

3. SingHealth Investigational Medicine Unit Singapore Health Services Singapore Singapore

4. Singapore Clinical Research Institute Singapore Singapore

5. Experimental Therapeutics Centre A*STAR Singapore Singapore

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.12678